Search Results - Erik H. Niks

Refine Results
  1. 1
    Exon skipping: a first in class strategy for Duchenne muscular dystrophy

    Exon skipping: a first in class strategy for Duchenne muscular dystrophy by Erik H. Niks, Annemieke Aartsma‐Rus

    Published 2016
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands

    Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands by Erik H. Niks, Jan B. M. Kuks, Jan J.G.M. Verschuuren

    Published 2006
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Prolonged Ambulation in Duchenne Patients with a Mutation Amenable to Exon 44 Skipping

    Prolonged Ambulation in Duchenne Patients with a Mutation Amenable to Exon 44 Skipping by J.C. van den Bergen, H.B. Ginjaar, Erik H. Niks, Annemieke Aartsma‐Rus, Jan J.G.M. Verschuuren

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Detecting dysphagia in inclusion body myositis

    Detecting dysphagia in inclusion body myositis by F. M. Cox, Jan J.G.M. Verschuuren, Berit M. Verbist, Erik H. Niks, Axel R. Wintzen, Umesh A. Badrising

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts

    An up-date on health-related quality of life in myasthenia gravis -results from population based cohorts by Marion Boldingh, Luuk Dekker, Angelina Maniaol, Cathrine Brunborg, Alexander F. Lipka, Erik H. Niks, Jan J.G.M. Verschuuren, Chantal Tallaksen

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis

    Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody‐binding epitopes in myasthenia gravis by Maartje G. Huijbers, Alexander F. Lipka, J. J. Plomp, Erik H. Niks, Silvère M. van der Maarel, Jan J.G.M. Verschuuren

    Published 2013
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations

    Salbutamol benefits children with congenital myasthenic syndrome due to DOK7 mutations by Georgina Burke, A. Hiscock, Andrea Klein, Erik H. Niks, Marion Main, Adnan Y. Manzur, Joanne Ng, C. De Vile, Francesco Muntoni, David Beeson, S. Robb

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy

    Evaluation of skeletal muscle DTI in patients with duchenne muscular dystrophy by Melissa T. Hooijmans, Bruce M. Damon, Martijn Froeling, Maarten J. Versluis, Jedrzej Burakiewicz, Jan J.G.M. Verschuuren, Erik H. Niks, Andrew Webb, Hermien E. Kan

    Published 2015
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Dystrophin isoform deficiency and upper‐limb and respiratory function in Duchenne muscular dystrophy

    Dystrophin isoform deficiency and upper‐limb and respiratory function in Duchenne muscular dystrophy by Mary Chesshyre, Deborah Ridout, Georgia Stimpson, Valeria Ricotti, Silvana De Lucia, Erik H. Niks, Volker Straub, Teresa Gidaro, Jean‐Yves Hogrel, Giovanni Baranello, Adnan Manzur, Francesco Muntoni

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy

    MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy by Karin J. Naarding, Harmen Reyngoudt, Erik W. van Zwet, Melissa T. Hooijmans, Cuixia Tian, I. Rybalsky, K. Shellenbarger, Julien Le Louër, Brenda Wong, Pierre G. Carlier, Hermien E. Kan, Erik H. Niks

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Myasthenia Gravis Thymus

    Myasthenia Gravis Thymus by Maria Isabel Leite, Margaret T. Jones, Philipp Ströbel, Alexander Marx, Ralf Gold, Erik H. Niks, Jan J.G.M. Verschuuren, Sonia Berrih‐Aknin, Francesco Scaravilli, Áurea Canelhas, B. Paul Morgan, Angela Vincent, Nick Willcox

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy

    Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy by N. Doorenweerd, Ahmed Mahfouz, Maaike van Putten, Rajaram Kaliyaperumal, Peter A.C. ‘t Hoen, Jos G.M. Hendriksen, Annemieke Aartsma‐Rus, Jan J.G.M. Verschuuren, Erik H. Niks, Marcel J. T. Reinders, Hermien E. Kan, Boudewijn P. F. Lelieveldt

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4

    MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4 by Maartje G. Huijbers, Wei Zhang, Rinse Klooster, Erik H. Niks, Matthew B. Friese, Kirsten R. Straasheijm, Peter Thijssen, Hans Vrolijk, Jaap J. Plomp, Pauline Vogels, Mario Losen, Silvère M. van der Maarel, Steven J. Burden, Jan J.G.M. Verschuuren

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice

    Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice by Rinse Klooster, Jaap J. Plomp, Maartje G. Huijbers, Erik H. Niks, Kirsten R. Straasheijm, Frank Detmers, Pim Hermans, Kevin Sleijpen, Aad Verrips, Mario Losen, Pilar Martínez‐Martínez, Marc H. De Baets, Silvère M. van der Maarel, Jan J.G.M. Verschuuren

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls

    Real-world and natural history data for drug evaluation in Duchenne muscular dystrophy: suitability of the North Star Ambulatory Assessment for comparisons with external controls by Francesco Muntoni, James Signorovitch, Gautam Sajeev, Nathalie Goemans, Brenda Wong, Cuixia Tian, Eugenio Mercuri, Nicolae Done, Hallee E. Wong, Jackson Moss, Zhiwen Yao, Susan J. Ward, Adnan Manzur, Laurent Servais, Erik H. Niks, Volker Straub, Imelda JM de Groot, Craig M. McDonald

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Fibronectin is a serum biomarker for <scp>D</scp>uchenne muscular dystrophy

    Fibronectin is a serum biomarker for <scp>D</scp>uchenne muscular dystrophy by F. Cynthia Martin, Monika Hiller, Pietro Spitali, Stijn Oonk, Hans Dalebout, Magnus Palmblad, Amina Chaouch, Michela Guglieri, Volker Straub, Hanns Lochmüller, Erik H. Niks, Jan J.G.M. Verschuuren, Annemieke Aartsma‐Rus, André M. Deelder, Yuri E. M. van der Burgt, Peter A.C. ‘t Hoen

    Published 2014
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies

    Tracking disease progression non‐invasively in Duchenne and Becker muscular dystrophies by Pietro Spitali, Kristina Hettne, Roula Tsonaka, Mohammed Charrout, Janneke van den Bergen, Zaïda Koeks, Hermien E. Kan, Melissa T. Hooijmans, Andreas Roos, Volker Straub, Francesco Muntoni, Cristina Al‐Khalili Szigyarto, Marleen J.A. Koel‐Simmelink, Charlotte E. Teunissen, Hanns Lochmüller, Erik H. Niks, Annemieke Aartsma‐Rus

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy

    Determining minimal clinically important differences in the North Star Ambulatory Assessment (NSAA) for patients with Duchenne muscular dystrophy by Vandana Ayyar Gupta, Jacqueline Pitchforth, Joana Domingos, Deborah Ridout, Mario Iodice, Catherine Rye, Mary Chesshyre, Amy Wolfe, Victoria Selby, Anna Mayhew, Elena Mazzone, Valeria Ricotti, Jean‐Yves Hogrel, Erik H. Niks, Imelda J. M. de Groot, Laurent Servais, Volker Straub, Eugenio Mercuri, Adnan Y. Manzur, Francesco Muntoni

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study

    Meaningful changes in motor function in Duchenne muscular dystrophy (DMD): A multi-center study by Francesco Muntoni, James Signorovitch, Gautam Sajeev, Nicolae Done, Zhiwen Yao, Nathalie Goemans, Craig M. McDonald, Eugenio Mercuri, Erik H. Niks, Brenda Wong, Krista Vandenborne, Volker Straub, Imelda J. M. de Groot, Cuixia Tian, Adnan Manzur, Ibrahima Dieye, H. Clifford Lane, Susan J. Ward, Laurent Servais

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Reduced cerebral gray matter and altered white matter in boys with <scp>D</scp>uchenne muscular dystrophy

    Reduced cerebral gray matter and altered white matter in boys with <scp>D</scp>uchenne muscular dystrophy by N. Doorenweerd, C.S.M. Straathof, Eve M. Dumas, Pietro Spitali, Ieke B. Ginjaar, Beatrijs Wokke, D.G.M. Schrans, J.C. van den Bergen, Erik W. van Zwet, Andrew Webb, Mark A. van Buchem, Jan J.G.M. Verschuuren, Jos G.M. Hendriksen, Erik H. Niks, Hermien E. Kan

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: